Amgen Inc.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…
Drug Manufacturers - General
US, Thousand Oaks [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Amgen Inc.'s gradings, price targets and earnings estimates. None
FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
E | E | E | E | E | E | |||||||
2014 | 6.7500 | 7.640 | 18,676 | 18,889 | 5,081 | 4,791 | 6,287 | 8,145 | 5,867 | 5,754 | 5,184 | 4,390 |
2015 | 6.8000 | 10.084 | 20,063 | 21,644 | 5,158 | 6,032 | 6,656 | 9,729 | 6,191 | 7,366 | 4,699 | 4,217 |
2016 | 9.1500 | 11.556 | 21,662 | 22,792 | 6,939 | 7,198 | 9,073 | 11,681 | 8,470 | 9,132 | 4,846 | 4,726 |
2017 | 10.3200 | 12.701 | 22,991 | 22,900 | 7,722 | 1,463 | 10,423 | 12,491 | 9,794 | 9,682 | 5,062 | 4,760 |
2018 | 2.7100 | 14.272 | 22,849 | 23,373 | 1,979 | 7,824 | 10,901 | 12,010 | 9,973 | 9,566 | 4,870 | 4,979 |
2019 | 12.7000 | 14.599 | 23,747 | 23,186 | 8,394 | 7,409 | 10,937 | 11,940 | 10,263 | 9,142 | 5,332 | 4,870 |
2020 | 12.9600 | 16.076 | 23,362 | 25,362 | 7,842 | 6,370 | 10,427 | 11,401 | 9,674 | 8,018 | 5,150 | 5,026 |
2021 | 12.4000 | 16.823 | 25,424 | 26,002 | 7,264 | 5,705 | 9,395 | 10,922 | 9,139 | 7,396 | 5,730 | 5,177 |
2022 | 10.3400 | 17.681 | 25,979 | 26,171 | 5,893 | 6,493 | 9,403 | 11,942 | 9,144 | 9,197 | 5,368 | 5,201 |
2023 | 12.1800 | 18.557 | 26,323 | 28,117 | 6,552 | 6,717 | 8,752 | 13,136 | 9,566 | 10,117 | 5,414 | 5,721 |
2024 | 12.5600 | 19.581 | 28,190 | 33,167 | 6,717 | 10,534 | 14,801 | 13,501 | 7,897 | 9,331 | 6,179 | 7,146 |
2025 | - | 20.737 | - | 34,343 | - | 11,246 | - | 13,979 | - | 9,662 | - | 7,399 |
2026 | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
2027 | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
2028 | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |